| Drug Name |
Specs. |
Indication |
Status |
| Acitretin |
EP |
Retinoid, treatment of psoriasis |
DMF in preparation |
| Atipamezole HCl |
In-house |
Reversal of the sedative and analgesic effects of medetomidine in dogs |
DMF in preparation |
| Bosentan |
In-house |
Pulmonary artery hypertension (PAH) |
DMF in preparation |
| Calcipotriol |
EP |
Treatment of psoriasis |
DMF in preparation |
| Diatrizoic Acid |
USP/EP |
Contrast media agent |
GMP certificate |
| Droperidol |
USP/EP |
Antiemetic, antipsychotic |
GMP certificate |
| Doxapram HCl |
|
Stimulating respiration |
GMP certificate |
| Fulvestrant |
In-house |
Metastatic breast cancer |
US DMF available |
| Gadopentetic Acid |
In-house |
MRI contrast agent |
JMF available |
| Ibutilide fumarate |
In-house |
Acute cardioconversion and atrial flutter |
DMF available |
| Melphalan HCl |
In-house |
Multiple myeloma and ovarian cancer |
DMF available |
| Meglumine |
USP/CP |
in conjunction with iodinated compounds |
GMP certificate |
| Metolazone |
USP |
Diuretic |
US DMF available |
| Medetomidine HCl |
In-house |
Surgical anesthetic and analgesic in dogs |
DMF in preparation |
| Nicorandil |
JP |
Vasodilatory to treat angina |
GMP certificate |
| Propofol |
USP/EP |
Sedative-hypnotic agent |
GMP certificate |
| Ropinirole HCl |
USP |
Parkinson's disease |
DMF available |
| Ropivacaine HCl |
USP |
Local anesthetic |
USDMF No. 20249 US-FDA Approval |
| Ropivacaine Mesylate |
CP |
Local anesthetic |
GMP certificate |
| Succinylcholine Chloride |
USP/EP |
Muscle relaxation and short term paralysis |
DMF available |